Deep semi-supervised learning for brain tumor classification

Background This paper addresses issues of brain tumor, glioma, classification from four modalities of Magnetic Resonance Image (MRI) scans (i.e., T1 weighted MRI, T1 weighted MRI with contrast-enhanced, T2 weighted MRI and FLAIR). Currently, many available glioma datasets often contain some unlabeled brain scans, and many datasets are moderate in size. Methods We propose to exploit deep semi-supervised learning to make full use of the unlabeled data. Deep CNN features were incorporated into a new graph-based semi-supervised learning framework for learning the labels of the unlabeled data, where a new 3D-2D consistent constraint is added to make consistent classifications for the 2D slices from the same 3D brain scan. A deep-learning classifier is then trained to classify different glioma types using both labeled and unlabeled data with estimated labels. To alleviate the overfitting caused by moderate-size datasets, synthetic MRIs generated by Generative Adversarial Networks (GANs) are added in the training of CNNs. Results The proposed scheme has been tested on two glioma datasets, TCGA dataset for IDH-mutation prediction (molecular-based glioma subtype classification) and MICCAI dataset for glioma grading. Our results have shown good performance (with test accuracies 86.53% on TCGA dataset and 90.70% on MICCAI dataset). Conclusions The proposed scheme is effective for glioma IDH-mutation prediction and glioma grading, and its performance is comparable to the state-of-the-art.

[1]  Wei Cao,et al.  Deep Learning based Radiomics (DLR) and its usage in noninvasive IDH1 prediction for low grade glioma , 2017, Scientific Reports.

[2]  Pier Giorgio Masci,et al.  Probing the intravascular and interstitial compartments of remodeled myocardium in heart failure patients with preserved and reduced ejection fraction: a CMR study , 2019, BMC Medical Imaging.

[3]  Yan Wang,et al.  Multimodal 3D DenseNet for IDH Genotype Prediction in Gliomas , 2018, Genes.

[4]  S. Qi,et al.  Isocitrate dehydrogenase mutation is associated with tumor location and magnetic resonance imaging characteristics in astrocytic neoplasms , 2014, Oncology letters.

[5]  Raymond Y Huang,et al.  Residual Convolutional Neural Network for the Determination of IDH Status in Low- and High-Grade Gliomas from MR Imaging , 2017, Clinical Cancer Research.

[6]  Brian B. Avants,et al.  The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS) , 2015, IEEE Transactions on Medical Imaging.

[7]  R. Jenkins,et al.  Genetics of adult glioma. , 2012, Cancer genetics.

[8]  Irene Y. H. Gu,et al.  3D Multi-Scale Convolutional Networks for Glioma Grading Using MR Images , 2018, 2018 25th IEEE International Conference on Image Processing (ICIP).

[9]  Baojuan Li,et al.  Radiomics Strategy for Molecular Subtype Stratification of Lower‐Grade Glioma: Detecting IDH and TP53 Mutations Based on Multimodal MRI , 2018, Journal of magnetic resonance imaging : JMRI.

[10]  D. Busam,et al.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.

[11]  Yuanyuan Wang,et al.  Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma , 2017, European Radiology.

[12]  Sabine Van Huffel,et al.  Semi-automated brain tumor segmentation on multi-parametric MRI using regularized non-negative matrix factorization , 2017, BMC Medical Imaging.

[13]  T. Cloughesy,et al.  Relationship between Tumor Enhancement, Edema, IDH1 Mutational Status, MGMT Promoter Methylation, and Survival in Glioblastoma , 2012, American Journal of Neuroradiology.

[14]  Yannis Avrithis,et al.  Label Propagation for Deep Semi-Supervised Learning , 2019, 2019 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR).

[15]  Jie Yang,et al.  Enlarged Training Dataset by Pairwise GANs for Molecular-Based Brain Tumor Classification , 2020, IEEE Access.

[16]  S. Torp,et al.  Surgical resection versus watchful waiting in low-grade gliomas , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  G. Reifenberger,et al.  Patients with IDH 1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH 1-mutated glioblastomas , and IDH 1 mutation status accounts for the unfavorable prognostic effect of higher age : implications for classification of gliomas , 2010 .

[18]  Wenya Linda Bi,et al.  Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low- and high-grade gliomas , 2019, Journal of Neuro-Oncology.

[19]  F. Ducray,et al.  IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.

[20]  Bernhard Schölkopf,et al.  Learning with Local and Global Consistency , 2003, NIPS.

[21]  Christos Davatzikos,et al.  Advancing The Cancer Genome Atlas glioma MRI collections with expert segmentation labels and radiomic features , 2017, Scientific Data.

[22]  Seung Hong Choi,et al.  Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade. , 2011, Radiology.

[23]  Bozena Kaminska,et al.  Consequences of IDH1/2 Mutations in Gliomas and an Assessment of Inhibitors Targeting Mutated IDH Proteins , 2019, Molecules.

[24]  Dafna Ben-Bashat,et al.  MRI radiomics analysis of molecular alterations in low-grade gliomas , 2018, International Journal of Computer Assisted Radiology and Surgery.

[25]  Ranran Sun,et al.  A potential field segmentation based method for tumor segmentation on multi-parametric MRI of glioma cancer patients , 2019, BMC Medical Imaging.

[26]  Yusong Lin,et al.  Automatic glioma segmentation based on adaptive superpixel , 2019, BMC Medical Imaging.

[27]  Yue-Hua Li,et al.  Effect of region of interest on ADC and interobserver variability in thyroid nodules , 2019, BMC Medical Imaging.

[28]  Weimin Huang,et al.  Brain tumor grading based on Neural Networks and Convolutional Neural Networks , 2015, 2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).